Announcements Trials
Browse Landscape

Status

Completed 2Suspended 1

Sponsor Class

OTHER 3

Study Type

Interventional 7Observational 3

Sponsor

Cancer Type

Genitourinary 3Other 1Lymphoid 1Head & Neck 1

Conditions

Prostatic Neoplasms 1216Urinary Bladder Neoplasms 387Carcinoma, Renal Cell 329Kidney Neoplasms 205Neoplasms 157Breast Neoplasms 146Lung Neoplasms 101Carcinoma, Transitional Cell 100Colorectal Neoplasms 77Testicular Neoplasms 74Ovarian Neoplasms 62Melanoma 60Pancreatic Neoplasms 57Colonic Neoplasms 50Carcinoma, Non-Small-Cell Lung 50Head and Neck Neoplasms 47Disease 47Stomach Neoplasms 45Non-Muscle Invasive Bladder Neoplasms 45Neoplasm Metastasis 41Liver Neoplasms 40Uterine Cervical Neoplasms 39Esophageal Neoplasms 37Wilms Tumor 36Prostatic Hyperplasia 36Adenocarcinoma 33Multiple Myeloma 32Urologic Neoplasms 30Sarcoma 30Recurrence 30

Interventions

Specimen Handling 1Mental Status and Dementia Tests 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Hypogonadism × Genitourinary × Clear all
NCT06191575 2026-06-05

7 Tesla MRI Neuroimaging in Testicular Cancer Patients With Hypogonadism and on Androgen Replacement Therapy

University of Southern California

Suspended
10 enrolled
Genitourinary

Hypogonadism, Testicular Neoplasms

NCT03063125 2021-08-03

Perioperative Hypogonadism in Men Undergoing Radical Cystoprostatectomy for Bladder Cancer

University of Kansas Medical Center

Completed
25 enrolled 9 charts
Genitourinary

Urinary Bladder Neoplasms, Hypogonadism

NCT02240966 2016-07-14

Symptoms and Clinical Signs of Hypogonadism in Testicular Cancer Survivors

Rigshospitalet, Denmark

Completed
200 enrolled
Genitourinary

Hypogonadism, Testicular Neoplasms, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡